Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer With Metastatic Bone Disease
Interventions: DRUG: Zoledronic acid
Sponsor: Novartis